Reader Case: Future Empty Nesters
Hello all! Well, it’s been a while since we took a look at our inbox, so let’s dive in there and see what…
Category: news
The Recession That Isn’t Happening
Editor’s Note: Today we’re doing something rare… We’re sharing the lead article from this month’s issue of Chief Income Strategist Marc Lichtenfeld’s newsletter,…
A Cannabis Value Play: AdvisorShares Pure US Cannabis ETF
On August 30, we received the biggest development regarding the United States’ drug policy in 50 years. The U.S. Department of Health and…
KFF Health News: Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered…
Medical Properties Trust: This 9% Yield Is No Longer Safe
It’s not often that Safety Net gets it wrong, especially when it comes to dividends it deems safe. Last year, we looked at…
Is This the Perfect Time to Buy Bonds?
In last week’s State of the Market video, I talked about how there’s no such thing as a Goldilocks, or “just right,” market….
The Most Epic Babymoon
“Is this a good time? Are you sitting down?” I took a deep breath. I was sitting down, the bus ride was bumpy…
How Snake Wrangling Can Help You Become a Better Investor
Last week, Chief Income Strategist Marc Lichtenfeld received a harrowing text from his son… Marc immediately jumped into action. And when it was…
Should You Invest in Baytex Energy?
The last time I got really excited about the valuation of an oil producer was in October 2021. The stock was Cenovus Energy…